An AI-driven tool that tailors antidepressant treatment to individual patients was shown to improve outcomes for people with depression, compared to standard treatment, in a major international trial.
Acurx Pharmaceuticals, Inc. ("Acurx" or the "Company"), a clinical stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, today announced ...
Inimmune Corporation, a clinical-stage biotechnology company developing novel immunotherapies for allergic diseases, today announced the completion of enrollment and dosing of the first patient in its ...
Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...
A web-based tool that incorporates patient preference in antidepressant selection was associated with a significant decrease ...
Profound Medical Corp. (NASDAQ:PROF) Q4 2025 Earnings Call Transcript March 6, 2026 Operator: Good day, and thank you for standing by. Welcome to the Profound Medical Fourth Quarter 2025 Financial ...
The newly introduced AI-powered study build engine marks the first phase of ClinCapture's broader intelligent trial roadmap. By automating protocol translation, Captivate establishes a foundation for ...
Myomo, Inc. ( MYO) Q4 2025 Earnings Call March 9, 2026 4:30 PM EDT Good day, and welcome to the Myomo Fourth Quarter and Full Year 2025 Financial Results. [Operator Instructions] Please note, this ...
Risk-bearing provider organizations rely on physicians to achieve cost savings. The literature on physician-mediated interventions to reduce costs is scant and provides little guidance on effective ...
Three of the top diabetes tech companies put forward new clinical data this week, making the case for their continuous glucose monitors and insulin pumps as they look to expand their reac | Three ...
Profound Medical (NASDAQ:PROF) reported fourth-quarter 2025 revenue of $6.0 million, including $2.3 million in recurring ...
The VISERA ELITE™ III Platform Was Developed by the SONY Olympus Medical Joint VentureWESTBOROUGH, Mass., 2026 /PRNewswire/ -- Olympus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results